Company intelligence / Profile preview

Kardionav

Fort Mill, South Carolina, United States

Ownership: Private
Development stage: Other

Overview

Kardionav is a recently formed joint venture focused on developing advanced, AI-driven mapping and ablation technologies for ventricular tachycardia; as of mid-2025, the primary product is in pre-clinical development, with no published clinical results yet[1][2][5].

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Chelak iECG

Beyond the preview

Go deeper on Kardionav.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kardionav.

Explore the full profile